Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Considering depression as a consequence of activation of the inflammatory response system.
New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Human myelin proteome and comparative analysis with mouse myelin.
A white matter lesion-filling approach to improve brain tissue volume measurements.
Clinical and epidemiological profiles of non-traumatic myelopathies.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Extracellular Vesicles and a Novel Form of Communication in the Brain.
Emerging functions of the Quaking RNA-binding proteins and link to human diseases.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Pages
« first
‹ previous
…
719
720
721
722
723
724
725
726
727
…
next ›
last »